Aditxt (ADTX) News Today $0.02 -0.01 (-39.82%) Closing price 04:00 PM EasternExtended Trading$0.02 +0.00 (+5.47%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Aditxt, Inc. Announces Reverse Stock Split PlanMarch 12 at 5:04 PM | tipranks.comAditxt announces 1-for-250 reverse stock split effective March 17March 12 at 5:00 PM | markets.businessinsider.comAditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025March 12 at 4:34 PM | businesswire.comAditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany ...March 7, 2025 | businesswire.comAditxt’s Adimune to ship substances for product formulation of of ADI-100March 6, 2025 | markets.businessinsider.comAditxt approves reverse stock split, adjourns special meetingMarch 5, 2025 | investing.comIs the Market Bullish or Bearish on Aditxt?March 1, 2025 | benzinga.comAditxt, Inc. Discusses Pearsanta’s Planned IPO and InnovationsFebruary 24, 2025 | tipranks.comAditxt subsidiary Persanta engages Dominary Securities for IPOFebruary 21, 2025 | markets.businessinsider.comAditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025February 21, 2025 | businesswire.comAppili Therapeutics Inc.: Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025February 15, 2025 | finanznachrichten.deAditx Therapeutics stock hits 52-week low at $0.12January 21, 2025 | msn.comAditxt to explore taking Pearsanta subsidiary publicJanuary 13, 2025 | markets.businessinsider.comAditxt, Inc. Plans IPO for Pearsanta in 2025January 13, 2025 | tipranks.comAditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection PlatformJanuary 13, 2025 | finance.yahoo.comAditxt Advances ADI-100 Therapy to Human TrialsDecember 12, 2024 | tipranks.comAditxt extends merger agreement end date to January 2025November 21, 2024 | investing.comAppili Therapeutics shareholders vote in favor of Aditxt transactionNovember 14, 2024 | markets.businessinsider.comEvofem Biosciences Announces Financial Results for the Third Quarter of 2024November 14, 2024 | prnewswire.comAditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of SharesNovember 8, 2024 | finance.yahoo.comAditxt, Inc. Focuses on Growth Amid Nasdaq ComplianceNovember 6, 2024 | markets.businessinsider.comAditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary AdifemNovember 6, 2024 | businesswire.comEvofem Secures Investor Support for Proposed Merger through Voting AgreementsNovember 6, 2024 | prnewswire.comAditxt (NASDAQ:ADTX) Stock, Earnings Estimates, EPS, And RevenueOctober 16, 2024 | benzinga.comAditxt CEO Clarifies NASDAQ Compliance and Capital StrategyOctober 13, 2024 | finance.yahoo.comAditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight TimeOctober 9, 2024 | businesswire.comAditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With EvofemOctober 8, 2024 | finance.yahoo.comAditxt gears up for strategic acquisitions and Nasdaq complianceOctober 6, 2024 | uk.investing.comAditx Therapeutics Inc (ADTX)September 29, 2024 | investing.comAmazon staff threaten mass exodus following WFH banSeptember 27, 2024 | au.finance.yahoo.comAditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024September 27, 2024 | businesswire.comAditxt's Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025September 20, 2024 | businesswire.comAppili Therapeutics Inc.: Appili Therapeutics Announces Results of Annual and Special Meeting of ShareholdersSeptember 18, 2024 | finanznachrichten.deInvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Seeks Grant Funding to Advance Early Detection, Management of Prostate CancerSeptember 5, 2024 | msn.comInvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Announces Participation at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 29, 2024 | msn.comAditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024August 29, 2024 | businesswire.comEvofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral SolutionAugust 20, 2024 | prnewswire.comBioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Releases Second-Quarter 2024 Financial Results, Company UpdateAugust 14, 2024 | msn.comAditxt shareholders approve strategic proposalsAugust 14, 2024 | investing.comAditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders' Meeting, Setting the Stage for 2024 and 2025 Strategic PlansAugust 14, 2024 | stockhouse.comEvofem Biosciences Announces Financial Results for the Second Quarter of 2024August 14, 2024 | prnewswire.comAditxt swaps pre-funded warrants for preferred stock and new warrantsAugust 10, 2024 | uk.investing.comAditxt Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesAugust 9, 2024 | businesswire.comAditxt Announces $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesAugust 9, 2024 | businesswire.comAditxt Subsidiary Pearsanta Seeks Clinical Trial Translational Endpoints Research Award for Early Detection of Ovarian CancerAugust 7, 2024 | stockhouse.comBiotech Soars Despite Broader SelloffAugust 7, 2024 | msn.comFCA makes first crypto-related sting against Coinbase subsidiaryJuly 25, 2024 | uk.finance.yahoo.comEvofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1stJuly 25, 2024 | globenewswire.comEvofem Signs Phexxi® License Agreement for Middle East with Pharma 1July 23, 2024 | prnewswire.comWhat's Going On With Aditxt Shares Wednesday?July 19, 2024 | msn.com Remove Ads Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address ADTX Media Mentions By Week ADTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADTX News Sentiment▼0.670.73▲Average Medical News Sentiment ADTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADTX Articles This Week▼61▲ADTX Articles Average Week Remove Ads Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies InMed Pharmaceuticals News Titan Pharmaceuticals News Tharimmune News CNS Pharmaceuticals News NovaBay Pharmaceuticals News Genprex News Scinai Immunotherapeutics News Sunshine Biopharma News Matinas Biopharma News Lipella Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADTX) was last updated on 3/14/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredOur #1 Defense Stock for MarchChina just deepened its military alliance with America's enemies in the Middle East... By conducting joint ...Behind the Markets | SponsoredElon’s desperate gambleWarning: "DOGE Collapse" Imminent After months of cost-cutting, controversy, and media buzz, DOGE is on the...Altimetry | SponsoredTrump’s new tariffs could break China’s grip on manufacturingLooming trade wars have China scrambling… Over 90% of global corporate executives said they are shutting do...Weiss Ratings | SponsoredIs 2025 really the best time to get rich in American history?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMore important than tariffs for your stocksMost people are obsessed with Trump's on-again, off-again tariffs. Yes, the economic uncertainly is playin...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
